Risk of incident cardiovascular disease among patients with gastrointestinal disorder: prospective cohort study of 340,862 individuals
暂无分享,去创建一个
S. Larsson | J. Zhao | S. Li | S. Yuan | Jie Chen | X. Li | Xue Li | Yuhao Sun | T. Fu | S. Yuan | J. Chen | Y. Sun | W. Shi | T. Fu | S. Lu | S. Lu | Jianhui Zhao | Susanna C. Larsson | Wenming Shi | Shi-yuan Lu | Sen Li | Kong Hong | Kong
[1] J. Ryu,et al. Risk of cardiovascular disease and mortality in patients with diabetes and acute pancreatitis history: a nationwide cohort study , 2022, Scientific Reports.
[2] R. Horst,et al. Low-grade inflammation as mediator between diet and behavioral disinhibition: A UK Biobank study , 2022, Brain, Behavior, and Immunity.
[3] Liangrong Zheng,et al. A Mendelian Randomization Study to Assess the Genetic Liability of Gastroesophageal Reflux Disease for Cardiovascular Diseases and Risk Factors. , 2022, Human molecular genetics.
[4] Li Jin,et al. Dissecting causal relationships between nonalcoholic fatty liver disease proxied by chronically elevated alanine transaminase levels and 34 extrahepatic diseases. , 2022, Metabolism: clinical and experimental.
[5] C. Stehouwer,et al. Relationship between non-alcoholic fatty liver disease and coronary artery disease: A Mendelian randomization study. , 2022, Hepatology.
[6] Sang-Man Jin,et al. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study , 2022, Cardiovascular Diabetology.
[7] S. Larsson,et al. Gut microbiota–derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis , 2022, The American journal of clinical nutrition.
[8] Ta-Liang Chen,et al. Risk of acute atherosclerotic cardiovascular disease in patients with acute and chronic pancreatitis , 2021, Scientific Reports.
[9] M. Hill,et al. Inflammatory bowel disease and cardiovascular diseases: a concise review , 2021, European heart journal open.
[10] J. Ludvigsson,et al. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort , 2021, Gut.
[11] A. Mortara,et al. Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population , 2021, Frontiers in Endocrinology.
[12] E. Rimm,et al. History of Diverticulitis and Risk of Incident Cardiovascular Disease in Men: A Cohort Study , 2021, Digestive Diseases and Sciences.
[13] Yuan-Lin Guo,et al. Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease , 2021, Hepatology International.
[14] A. Naaraayan,et al. Atherosclerotic Cardiovascular Disease Prevalence Among Patients With Celiac Disease in the United States: An Observational Study. , 2021, Mayo Clinic proceedings.
[15] E. Benjamin,et al. Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study , 2020, Hepatology.
[16] H. Kamel,et al. Gastrointestinal Disorders and Risk of First-Ever Ischemic Stroke , 2020, Stroke.
[17] L. Liaudet,et al. Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications , 2020, Nature Reviews Cardiology.
[18] S. Larsson,et al. Effects of tumour necrosis factor on cardiovascular disease and cancer: A two-sample Mendelian randomization study , 2020, EBioMedicine.
[19] S. Hazen,et al. Gut Microbiota and Cardiovascular Disease , 2020, Circulation research.
[20] A. Linneberg,et al. Long-term Consequences of Undiagnosed Celiac Seropositivity. , 2020, The American journal of gastroenterology.
[21] G. Andersen,et al. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions , 2020, EBioMedicine.
[22] F. Bäckhed,et al. Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.
[23] Yuquan Wei,et al. Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors , 2018, Oncotarget.
[24] E. Loftus,et al. Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[25] B. Nordestgaard,et al. Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals , 2018, European heart journal.
[26] J. Richman,et al. New-Onset Cardiovascular Morbidity in Older Adults With Stage I to III Colorectal Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] Kyunga Kim,et al. Associations between reflux esophagitis and the progression of coronary artery calcification: A cohort study , 2017, PloS one.
[28] E. Horváth-Puhó,et al. Mortality and cardiovascular diseases risk in patients with Barrett's oesophagus: a population‐based nationwide cohort study , 2017, Alimentary pharmacology & therapeutics.
[29] J. Manson,et al. Gallstones and Risk of Coronary Heart Disease: Prospective Analysis of 270 000 Men and Women From 3 US Cohorts and Meta-Analysis. , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[30] Zhen Chen,et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy , 2016, Cancer.
[31] L. Qi,et al. Gallstone Disease and the Risk of Ischemic Heart Disease , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[32] E. Horváth-Puhó,et al. Diverticular disease is associated with increased risk of subsequent arterial and venous thromboembolic events. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[33] Siddharth Singh,et al. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[34] J. Windsor,et al. Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis , 2013, Gut.
[35] J. Burnett,et al. A gut-heart connection in cardiometabolic regulation , 2013, Nature Medicine.
[36] Liang-qiu Tang,et al. Relationship Between Helicobacter pylori Infection and Serum Interleukin‐18 in Patients with Carotid Atherosclerosis , 2013, Helicobacter.
[37] T. Shibasaki,et al. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure , 2013, Nature Medicine.
[38] H. Brenner,et al. Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study. , 2012, Atherosclerosis.
[39] C. Brensinger,et al. No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[40] I. Janszky,et al. Childhood appendectomy, tonsillectomy, and risk for premature acute myocardial infarction--a nationwide population-based cohort study. , 2011, European heart journal.
[41] D. Mozaffarian,et al. Components of a Cardioprotective Diet: New Insights , 2011, Circulation.
[42] Herng‐Ching Lin,et al. Reflux Esophagitis and the Risk of Stroke in Young Adults: A 1-Year Population-Based Follow-Up Study , 2010, Stroke.
[43] K. Nägga,et al. Homocysteine Levels in Chronic Gastritis and Other Conditions: Relations to Incident Cardiovascular Disease and Dementia , 2009, Digestive Diseases and Sciences.
[44] T. Fahey,et al. The association between coeliac disease and cardiovascular disease , 2007, Alimentary pharmacology & therapeutics.
[45] C. Land,et al. Coronary heart disease after radiotherapy for peptic ulcer disease. , 2005, International journal of radiation oncology, biology, physics.
[46] M. Wallander,et al. Is there any association between myocardial infarction, gastro‐oesophageal reflux disease and acid‐suppressing drugs? , 2003, Alimentary pharmacology & therapeutics.